Clariane Reaffirms 2025-2028 Revenue Growth Target of Around 4% Annually

• Clariane reaffirmed its 2023-2026 targets, including average annual organic revenue growth of about 5% on a pro forma basis.
• Targets include a 100-150-basis-point improvement in pre-IFRS 16 EBITDA margin from 2023, with Wholeco leverage below 5.5 times by end-2026.
• For 2025-2028, pro forma annual growth targets remain around 4% for revenue, with pre-IFRS 16 EBITDA growth of 7%-9%.
• Pro forma operating-company EBITDA is targeted to grow 11%-14% annually, with Wholeco leverage around five times by end-2028.
• Nine-month 2026 revenue reached EUR 4.05 billion, up 4.7% organically, supported by higher volumes, pricing and favorable case mix.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clariane SE published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610281352OMX_____CNEWS_FR_GNW1001280470_fr) on October 28, 2026, and is solely responsible for the information contained therein.